Centocor - PDFSEARCH.IO - Document Search Engine

Centocor
Results: 172

#	Item
61	Sustainable Raritan River Business Round Table – September[removed]Johnson & Johnson/Ortho McNeil The Fall Sustainable Raritan River Business Roundtable took place at the Ortho McNeil facility of Johnson & Johnson on Thu Add to Reading List Source URL: www.raritan.rutgers.edu Language: English - Date: 2011-10-18 00:00:00 Johnson & Johnson Centocor New Brunswick New Jersey Sustainability Ortho-McNeil Pharmaceutical Earth Environment Environmental economics Environmental social science
62	Awards & Recognitions 2013 Thomson Reuters: Thompson Reuters has named Johnson & Johnson as one of its Top 100 Global Innovators for[removed]In making the selection, Thomson Reuters noted Johnson &Johnson had 653 unique in Add to Reading List Source URL: www.jnj.com Language: English - Date: 2013-10-09 11:56:32 New Brunswick New Jersey Economy of the United States Samuel Curtis Johnson Jr. Centocor Dow Jones Industrial Average Johnson & Johnson
63	SIMPONI® (golimumab) SIMPONI® (golimumab) MEDICATION GUIDE Add to Reading List Source URL: www.simponione.com Language: English - Date: 2014-03-24 06:12:32 Health Monoclonal antibodies Centocor Medical equipment Arthritis Golimumab Autoinjector Infliximab Rheumatoid arthritis Medicine Pharmacology Immunosuppressants
64	Apremilast (Otezla®) Medication Precertification Request Form Add to Reading List Source URL: www.aetna.com Language: English - Date: 2014-09-08 04:51:05 Pharmacology Psoriasis Monoclonal antibodies Health Arthritis Psoriatic arthritis Infliximab Etanercept Pharmacy Immunosuppressants Centocor Medicine
65	The Johnson Medal For Research And Development SIMPONI® (golimumab) and SmartJect® Team For patients with rheumatologic diseases, subcutaneous agents have required frequent injections. SIMPONI® (golimumab) and SmartJe Add to Reading List Source URL: www.jnj.com Language: English - Date: 2013-05-22 12:29:45 Golimumab Johnson & Johnson Pharmaceutical sciences Biologic Autoinjector Monoclonal antibodies Pharmaceutical drug Pharmacology Centocor Medicine
66	Consumer Health Information www.fda.gov/consumer Psoriasis Treatments Are Getting More Personalized Add to Reading List Source URL: www.fda.gov Language: English Health Immunosuppressants Centocor Ustekinumab Light therapy Biologic Generalized pustular psoriasis Psoriatic nails Psoriasis Medicine Monoclonal antibodies
67	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl Add to Reading List Source URL: www.pmda.go.jp Language: English - Date: 2014-08-06 20:44:55 Immunosuppressants Autoimmune diseases Monoclonal antibodies Centocor Infliximab Psoriasis Biologic Adverse effect Pharmaceutical drug Medicine Health Pharmacology
68	October 5, 2001 IMPORTANT DRUG WARNING Dear Healthcare Professional: Centocor would like to inform you of important safety information for REMICADE® (infliximab), a biological therapeutic product indicated for the trea Add to Reading List Source URL: www.fda.gov Language: English Monoclonal antibodies Immunosuppressants Tuberculosis Pharmacology Centocor Infliximab Immunosuppressive drug Biologic MedWatch Medicine Health Biology
69	healthcare provider letter Add to Reading List Source URL: www.fda.gov Language: English Immunosuppressants Monoclonal antibodies Autoimmune diseases Centocor Infliximab Schering-Plough Rheumatoid arthritis Biologic Arthritis Medicine Health Pharmacology
70	Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement Add to Reading List Source URL: www.janssen.com Language: English - Date: 2014-11-14 09:39:18 Piperazines Centocor Immunosuppressants Monoclonal antibodies Amines Tapentadol Ustekinumab Infliximab Levofloxacin Chemistry Pharmacology Organic chemistry

UPDATE